Nov 2 (Reuters) - Pfizer raised its annual profit and revenue forecasts on Tuesday, banking on strong demand for its cancer drugs and blockbuster blood thinner Eliquis. The U.S. drugmaker expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results